TERT and cancer: The frequently mutant TERT promoter (pTERT) forms de novo ETS family transcription factor binding sites and increases transcriptional activity in cancer cells by selectively recruiting ETS transcription factors, such as GABPA 3, ultimately activating telomerase and leading to cell immortalization 4.